These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26269361)

  • 1. Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills.
    Plu-Bureau G
    Evid Based Med; 2015 Oct; 20(5):189. PubMed ID: 26269361
    [No Abstract]   [Full Text] [Related]  

  • 2. Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism.
    Jick SS
    BMJ; 2015 May; 350():h2422. PubMed ID: 26013974
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New study supports MHRA advice on combined oral contraceptives.
    Harrison-Woolrych M; Woolley J
    BMJ; 2015 Jun; 350():h3305. PubMed ID: 26108434
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptive study omitted several confounders.
    Zagarella SS
    BMJ; 2015 Jun; 350():h3303. PubMed ID: 26108435
    [No Abstract]   [Full Text] [Related]  

  • 6. Authors' reply to Zagarella.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 Jun; 350():h3308. PubMed ID: 26109585
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the contraceptive pill and venous thromboembolism.
    Hannaford PC
    Thromb Res; 2011 Feb; 127 Suppl 3():S30-4. PubMed ID: 21262435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the removal of optionally retrievable caval filters: are we there yet?
    Janne d'Othée B
    J Vasc Interv Radiol; 2013 Jan; 24(1):40-2. PubMed ID: 23273696
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination oral contraceptives and the risk of venous thromboembolism.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):23-4. PubMed ID: 20336034
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraception and venous thromboembolism. A New Zealand perspective.
    Roke C
    Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CSM's warning about safety of third generation oral contraceptive. General practitioners in England prescribed second generation pills instead.
    Ferguson J; Jenkins MG
    BMJ; 1996 Aug; 313(7053):363. PubMed ID: 8760758
    [No Abstract]   [Full Text] [Related]  

  • 16. Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies.
    Emmerich J; Thomassin C; Zureik M
    J Thromb Haemost; 2014 Sep; 12(9):1388-90. PubMed ID: 25041638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism.
    Leppée M; Culig J
    J Fam Plann Reprod Health Care; 2012 Apr; 38(2):137-8. PubMed ID: 22454018
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral contraceptives for acne treatment: US Dermatologists' knowledge, comfort, and prescribing practices.
    Fitzpatrick L; Mauer E; Chen CL
    Cutis; 2017 Mar; 99(3):195-201. PubMed ID: 28398414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.